Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
PALO ALTO, Calif., Nov. 21, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the 6th Annual Evercore ISI HealthCONx Conference in Miami, Florida on Wednesday, November 29, 2023, at 3:25 p.m. Eastern Time (12:25 p.m. Pacific Time).
Related news for (KOD)
- Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)
- Kodiak Sciences to Present at American Chemical Society Fall 2025
- Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results
- Breaking News: MoBot’s Latest Update as of 07/24/25 04:00 PM
- Kodiak Sciences to Host Investor R&D Day on July 16, 2025